SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-18-331898
Filing Date
2018-11-21
Accepted
2018-11-21 08:50:05
Documents
3
Period of Report
2018-11-16
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d614171d8k.htm 8-K 18881
2 EX-10.1 d614171dex101.htm EX-10.1 24636
3 EX-10.2 d614171dex102.htm EX-10.2 32381
  Complete submission text file 0001193125-18-331898.txt   77181
Mailing Address 200 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 200 SIDNEY STREET CAMBRIDGE MA 02139 617 945 9626
Seres Therapeutics, Inc. (Filer) CIK: 0001609809 (see all company filings)

IRS No.: 274326290 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37465 | Film No.: 181197066
SIC: 2834 Pharmaceutical Preparations